Invention Grant
US09273121B2 Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
有权
特异性结合和/或中和日本脑炎病毒(JEV)的人源化单克隆抗体及其用途
- Patent Title: Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
- Patent Title (中): 特异性结合和/或中和日本脑炎病毒(JEV)的人源化单克隆抗体及其用途
-
Application No.: US13941283Application Date: 2013-07-12
-
Publication No.: US09273121B2Publication Date: 2016-03-01
- Inventor: Ana P. Goncalvez , Robert H. Purcell , Ching-Juh Lai
- Applicant: THE UNITED STATES OF AMERICA as represented by the Secretary Department of Health and Human Services
- Applicant Address: US DC Washington
- Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Klarquist Sparkman, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/10 ; G01N33/569 ; A61K39/00

Abstract:
Disclosed herein are isolated humanized monoclonal antibodies that specifically bind Japanese encephalitis virus (JEV) with a binding affinity of about 1.0 nM or less. Nucleic acids encoding these antibodies, expression vectors including these nucleic acid molecules, and isolated host cells that express the nucleic acid molecules are also disclosed. Methods of treating, preventing, and/or ameliorating JEV infection in a subject with JEV also are disclosed. Additionally, the antibodies can be used to detect JEV in a sample, and methods of diagnosing JEV infection, or confirming a diagnosis of JEV infection in a subject, are disclosed herein that utilize these antibodies.
Public/Granted literature
Information query